Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 4, 2010, Pages 757-763

  Okuma, Kae ^a   Yamashita, Hideomi ^a   Kawana, Kei ^a   Nakagawa, Shunsuke ^a   Oda, Katsutoshi ^a   Nakagawa, Keiichi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

age; endometrial carcinoma; prognostic factors; radiation therapy; treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADJUVANT THERAPY; ADULT; AGE; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOLOGY; DIARRHEA; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTESTINE OBSTRUCTION; LEG EDEMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PERITONEAL CAVITY; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW; SALPINGOOOPHORECTOMY; UNIVARIATE ANALYSIS; ADJUVANT CHEMOTHERAPY; CARCINOMA; ENDOMETRIAL NEOPLASMS; HYSTERECTOMY; KAPLAN MEIER METHOD; MIDDLE AGED; TREATMENT OUTCOME;

AGE FACTORS; AGED; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACLITAXEL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 77954912121     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01202.x     Document Type: Review

References (24)

1. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994 10 : 31 46.
2. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrioid adenocarcinoma: The importance of the distinction between surgical stage and clinical stage - a Gynecologic Oncology Group study. Cancer 1996 77 : 1115 1121.
3. Abeler VM, Kjørstad KE. Endometrial adenocarcinoma in Norway. A study of a total population. Cancer 1991 67 : 3093 3103.
4. Irwin C, Levin W, Fyles A, Pintilie M, Manchul L, Kirkbride P. The role of adjuvant radiotherapy in carcinoma of the endometrium: results in 550 patients with pathologic stage I disease. Gynecol Oncol 1998 70 : 247 254.
5. Poulsen MG, Roberts SJ. Prognostic variables in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1987 13 : 1043 1052.
6. Mundt AJ, Waggoner S, Yamada D, Rotmensch J, Connell PP. Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol Oncol 2000 79 : 79 85.
7. Grigsby PW, Perez CA, Kuten A et al. Clinical stage I endometrial cancer: Prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 1992 22 : 905 911.
8. Lindahl B, Ranstam J, Willén R. Five year survival rate in endometrial carcinoma stages I-II: Influence of degree of tumour differentiation, age, myometrial invasion and DNA content. Br J Obstet Gynaecol 1994 101 : 621 625.
9. Alektiar KM, McKee A, Venkatraman E et al. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer. Int J Radiat Oncol Biol Phys 2002 53 : 707 713.
10. Samet J, Hunt WC, Key C, Humble CG, Goodwin JS. Choice of cancer therapy varies with age of patient. JAMA 1986 255 : 3385 3390. (Pubitemid 16080858)
11. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001 93 : 850 857.
12. Alektiar KM, Venkatraman E, Abu-Rustum N, Barakat RR. Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 2003 98 : 2368 2377.
13. Creutzberg CL, Van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000 355 : 1404 1411.
14. Jolly S, Vargas CE, Kumar T et al. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Gynecol Oncol 2006 103 : 87 93.
15. Lee NK, Cheung MK, Shin JY et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 2007 109 : 655 662.
16. Farley JH, Nycum LR, Birrer MJ, Park RC, Taylor RR. Age-specific survival of women with endometrioid adenocarcinoma of the uterus. Gynecol Oncol 2000 79 : 86 89.
17. Manton KG, Vaupel JW. Survival after the age of 80 in the United States, Sweden, France, England, and Japan. N Engl J Med 1995 333 : 1232 1235.
18. Taeuber CM. Sixty-five plus in America. Current Population Reports. Special Studies. Washington, DC: US Department of Commerce, Economics and Statistics Administration, Bureau of the Census, 1996 publication no. P23-173RV.
19. The Cancer Committee of the Japan Society of Gynecology The 41st treatment annual report. 5-year result of treatment started in 1993 for cervical and endometrial carcinoma J Jpn Soc Obstet Gynecol 2008 60 : 1876 1901
20. In Japanese ME, Brunetto VL, Muss H. Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group. Proc Am Soc Clin Oncol 2003 22 : 2.
21. Randall ME, Spirtos NM, Dvoretsky P. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study no. 122. J Natl Cancer Inst Monogr 1995 19 : 13 15.
22. Susumu N, Sagae S, Udagawa Y et al. Japanese Gynecologic Oncology Group. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008 108 : 226 233.
23. Jolly S, Vargas C, Kumar T et al. Vaginal brachytherapy alone: An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 2005 97 : 887 892.
24. Solhjem MC, Petersen IA, Haddock MG. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys 2005 62 : 1379 1384.